Across the state, 2,408 people were hospitalized for COVID-19 Saturday. That’s up from a recent low of 1,209 on Nov. 6, and six times the number of people hospitalized from COVID-19 at the year-to-date low mark of 369 on June 24.
The omicron variant is likely to have picked up genetic material from another virus that causes the common cold in humans, according to a new preliminary study.
U.S. health officials said while the omicron variant of is rapidly spreading throughout the country, early indications suggest it might be less dangerous than delta, which continues to drive a surge of hospitalizations.
CEO Ugur Sahin told Reuters on Friday that he could foresee a scenario where coronavirus vaccine shots became annual, like flu shots.
The omicron variant of COVID-19, which had been undetected in the United States before the middle of this week, had been discovered in at least five states by late Thursday.
COVID-19 patients now occupy 26.3% of Indiana’s intensive care unit beds.
A person in California who had been vaccinated against COVID-19 became the first in the United States to have an identified case of the omicron variant, the White House announced Wednesday.
The return of stricter COVID-19 restrictions to fight the latest variant has already left some travelers stranded. For many tourism businesses, it’s also threatening hopes of an upcoming holiday boost this year.
The Centers for Disease Control and Prevention said in a Tuesday statement that it was working toward requiring that all air travelers to the U.S. be tested for COVID-19 within a day before boarding their flight.
The Food and Drug Administration panel voted 13-10 that the antiviral drug’s benefits outweigh its risks, including potential birth defects if used during pregnancy.
Indiana’s top medical groups pleaded Tuesday for more people to get COVID-19 vaccine shots as the state is in the midst of a new surge of infections and hospitalizations.
New findings about the coronavirus’s omicron variant made it clear Tuesday that the emerging threat slipped into countries before their defenses were up.
If authorized, Merck’s pill would be the first that U.S. patients could take at home to ease symptoms and speed recovery, but new information released last week paints a less compelling picture of the drug than when the Merck first publicized its early results in October.
Federal Reserve Chair Jerome Powell says that the appearance of a new COVID-19 variant could slow the economy and hiring.
A federal judge on Monday blocked President Joe Biden’s administration from enforcing a coronavirus vaccine mandate on thousands of health care workers in 10 states that had brought the first legal challenge against the requirement.
Statewide hospitalizations due to COVID-19 rose above the 2,000 mark over the weekend for the first time since late September, according to statistics released Monday by the Indiana State Department of Health
The most powerful lift for stocks came from those that have been able to grow strongly almost regardless of the economy’s strength or pandemic’s pall.
The COVID-19 variant was identified days ago by researchers in South Africa, and much is still not known about it, including whether it is more contagious, more likely to cause serious illness or more able to evade the protection of vaccines.
It was the worst day for Wall Street’s benchmark S&P 500 index since February, and the price of oil fell about 13%, the biggest decline since early in the pandemic, amid worries of another slowdown in the global economy.
A World Health Organization panel suggested omicron could pose greater risks than delta, which is the world’s most prevalent variant and has fueled relentless waves of infection on every continent.
